ATHENAS - Retrospective Analysis of Compliance to Treatment of Chronic Hepatitis C With Pegylated Interferon Alpha 2b Associated to Ribavirin Until Week 12 and Correlation With Virological Response in Brazil Health Centers.
Phase of Trial: Phase IV
Latest Information Update: 14 Oct 2011
At a glance
- Drugs Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms ATHENAS
- Sponsors Merck Sharp & Dohme; Schering-Plough
- 10 Jun 2017 Biomarkers information updated
- 14 Oct 2011 Actual patient number added 902 according to ClinicalTrials.gov.
- 10 Feb 2011 Actual End Date (1 Oct 2010) added as reported by ClinicalTrials.gov.